ScholarIQanswers from OpenAlex

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab

PaperCitations, authors & open-access status

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab have?

ScholarIQcitation count

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab has 180 citations in the OpenAlex counts ScholarIQ stores.

When was Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab published?

ScholarIQyear

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab has 2020 year in the ScholarIQ index.

What is the open-access status of Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab?

ScholarIQoa status

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab has green oa status in the ScholarIQ index.

What is the DOI of Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab?

ScholarIQdoi

The DOI for Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab is on the source record.

What is the PMID of Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab?

ScholarIQpmid

The PMID for Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab is on the source record.

What is the OpenAlex record for Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab?

ScholarIQopenalex

The OpenAlex for Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial